Polaris Group Announces Treatment of First Patient in Phase 1 Study…
Polaris Group is conducting clinical trials on ADI-PEG 20, both as monotherapy and in combination with other agents, for the treatment of several other indications, including breast cancer, melanomas, ovarian cancer, and hepatocellular carcinoma. The l…